Reference
Wang K, et al. A novel mutant PIK3R1EY451delinsD breast cancer patient resistant to HER2-targeted therapy treated with everolimus: a case report. Molecular Biology Reports 49: 6155-6160, No. 7, Jul 2022. Available from: URL: http://doi.org/10.1007/s11033-022-07407-z
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1921, 38 (2022). https://doi.org/10.1007/s40278-022-22032-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-22032-0